Management of diabetes and pancreatic cancer

MeSH terms

• Adenocarcinoma / complications
• Adenocarcinoma / diagnosis
• Adenocarcinoma / drug therapy*
• Adenocarcinoma / nursing
• Adenocarcinoma / surgery
• Antiemetics / adverse effects
• Antiemetics / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Combined Modality Therapy
• Dexamethasone / adverse effects
• Dexamethasone / therapeutic use
• Diabetes Mellitus, Type 2 / drug therapy*
• Diabetes Mellitus, Type 2 / etiology
• Disease Management
• Drug Resistance
• Drug Therapy, Combination
• Exenatide
• Fluorouracil / administration & dosage
• Fluorouracil / adverse effects
• Humans
• Hyperglycemia / chemically induced
• Hyperglycemic Hyperosmolar Nonketotic Coma / prevention & control
• Hypoglycemic Agents / therapeutic use*
• Insulin / therapeutic use
• Leucovorin / administration & dosage
• Leucovorin / adverse effects
• Male
• Malnutrition / etiology
• Malnutrition / prevention & control
• Metformin / therapeutic use
• Middle Aged
• Nausea / chemically induced
• Nausea / drug therapy
• Organoplatinum Compounds / administration & dosage
• Organoplatinum Compounds / adverse effects
• Oxaliplatin
• Palliative Care*
• Pancreatectomy
• Pancreatic Neoplasms / complications
• Pancreatic Neoplasms / diagnosis
• Pancreatic Neoplasms / drug therapy*
• Pancreatic Neoplasms / nursing
• Pancreatic Neoplasms / surgery
• Peptides / therapeutic use
• Sulfonylurea Compounds / therapeutic use
• Venoms / therapeutic use